SMRT Sequencing to be Featured in More Than 35 Presentations at the Annual AGBT Conference

Customers Demonstrate Value of PacBio Long-Read Solutions for Resolving Structural Variants, Targeted Sequencing and Isoform Sequencing ApplicationsMENLO PARK, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that data using its Single Molecule, Real-Time (SMRT®) Sequencing technology, including results from its Sequel™ System, will be featured in more than... Read more

SMRT Sequencing to be Featured in More Than 35 Presentations at the Annual AGBT Conference

Customers Demonstrate Value of PacBio Long-Read Solutions for Resolving Structural Variants, Targeted Sequencing and Isoform Sequencing ApplicationsMENLO PARK, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that data using its Single Molecule, Real-Time (SMRT®) Sequencing technology, including results from its Sequel™ System, will be featured in more than... Read more

10x Genomics Bolsters Commercial Leadership with the Appointment of Bradford J. Crutchfield as Chief Commercial Officer

PLEASANTON, Calif. – February 9, 2017 – 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced the appointment of Bradford J. Crutchfield as chief commercial officer of the company. Mr. Crutchfield will oversee global sales, marketing, business development and customer support. John Pouk, the company’s interim chief... Read more

Swift Biosciences Expands Team, Hires Vice President of Marketing

Ann Arbor, MI, February 8, 2017 – Swift Biosciences, today announced that it has hired Candia Brown as Vice President of Global Marketing. Brown brings over 25 years of biotechnology experience including product development, product management and market development. “Candia‘s deep expertise in the genomic tools market and associated applications coupled to her incredibly strong track record with... Read more

Integrated DNA Technologies acquires oligo manufacturing business of GeneWorks (Australia)

IDT expands its capacity for direct sales of genomic products in Asia-Pacific region SKOKIE, IL (February 8, 2017) – Integrated DNA Technologies (IDT), through its Singapore subsidiary, today completed the acquisition of the oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia. This acquisition sees IDT expand its reach in the Asia-Pacific region, following... Read more

IDT first to market with complete Cpf1-based CRISPR genome editing system

Expanded CRISPR toolkit includes Cpf1 and range of Alt-R™ support products, increasing the options available to molecular biology researchers CORALVILLE, IA (February 1, 2017) – Reflecting its drive to provide innovative solutions to the genomics community, Integrated DNA Technologies (IDT) is the first genomics company to develop and bring to market a complete ribonucleoprotein-based Cpf1... Read more

10x Genomics Collaborates with PerkinElmer to Jointly Offer Automated Next Generation Sequencing Solutions to Researchers

Combines award-winning Chromium™ System from 10x Genomics with PerkinElmer’s state-of-the-art automation solutions PLEASANTON, Calif., January 9, 2017 – 10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced they and PerkinElmer, Inc. will jointly offer automated next-generation sequencing (NGS) solutions. PerkinElmer’s automation solutions increase both the throughput... Read more

Cellecta, Inc. Receives Phase II NIH SBIR Grant to Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform

Development of a high-performance tool set for human and mouse genetic screens to enable enhanced drug discovery underway NEWS PROVIDED BY Cellecta, Inc. 26 Jan, 2017, 08:40 ET SHARE THIS ARTICLE MOUNTAIN VIEW, Calif., Jan. 26, 2017 /PRNewswire/ — Cellecta, Inc. today announced the receipt of Phase II SBIR grant funds from the National Institute of... Read more

Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc.

Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc. Mountain View, CA—January 18, 2017—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of Rubicon Genomics, Inc. (“Rubicon”), Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). Under the merger agreement executed with Rubicon,... Read more